NCL New Concept Lab GmbH

| IMAPlateTM 5RC96 - world's first miniaturized analytical platform capable of manually performing up to 96 liquid transfer, analysis, in-well reaction and assay in parallel and simultaneously in your lab bench. It is protected by a granted patent ZL 2007 8 0015956.7. The IMAPlate™ 5RC96 can be used as a fix volume 96-channel manual pipette to transfer up to 96 individual samples from one 96-well plate to another. It can also be used as a micro-cuvette for full spectrum analysis and measurement of a sample. Furthermore, it can replace the 96-well plate for many applications in medical and life science research with a working volume similar to a 1536-well plate. Due to the unique features, the IMAPlate™ 5RC96 can be used as a manual high-throughput tool for parallel reaction, assays and hanging drop 3D cell culture to enhance laboratory productivity. NCL New Concept Lab GmbH is a privately-owned company located at Moehlin, Switzerland – the region of BioValley Basel. The company is founded at the end of year 2006 and has already developed several proprietary and patent pending technologies, which have broad applications in pharmaceutical and biotech industries, healthcare facilities, universities and academic institutes.